The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Innovate, evaluate, expand
Australia is at the forefront of producing and trialling cutting-edge therapeutics. The industry is backed by a robust regulatory framework and bench to bedside innovation ecosystem, allowing businesses to do it all in Australia.
Summary
Australia is at the forefront of producing and trialling cutting-edge therapeutics. The industry is backed by a robust regulatory framework and bench to bedside innovation ecosystem, allowing businesses to do it all in Australia.
Benefits
The Australian life science industry has developed a critical mass over the past decade. It has grown by 40% since 2021 and has a market capitalisation of A$250 billion.
Benefits of doing business in Australia's life science sector include:
- exceptional health and medical research expertise
- bench-to-bedside innovation ecosystem
- world-class clinical trial capabilities
- government support including tax incentives
- reputation for quality data, robust regulation and intellectual property protection
- proximity and strong business links to the Asia Pacific.